Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-25 @ 3:53 AM
NCT ID:
NCT00031902
Eligibility Criteria:
DISEASE CHARACTERISTICS:
* Diagnosis of poor-prognosis, HIV-related non-Hodgkin's lymphoma (HIV-NHL)
* Previously untreated
* More than 1 of the following criteria:
* Prior diagnosis of AIDS
* ECOG performance status 3-4
* CD4 count less than 100/mm3
* No primary cerebral lymphoma
PATIENT CHARACTERISTICS:
Age:
* 18 and over
Performance status:
* See Disease Characteristics
Life expectancy:
* Not specified
Hematopoietic:
* Not specified
Hepatic:
* Not specified
Renal:
* Not specified
PRIOR CONCURRENT THERAPY:
Biologic therapy:
* Not specified
Chemotherapy:
* No prior chemotherapy for HIV-NHL
* At least 1 year since prior chemotherapy for Kaposi's sarcoma (KS)
Endocrine therapy:
* Not specified
Radiotherapy:
* Prior radiotherapy for HIV-NHL allowed
* At least 1 year since prior radiotherapy for KS
Surgery:
* Not specified
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00031902
Study Brief:
Protocol Section:
NCT00031902